HSHHSH Health Technology Supplier Hub

All suppliers

Showing 1–25 of 136 · North America

10x GenomicsHQ United States · North America
Genomics & precision medicine

FY2025 revenue $642.8m (+5.2%); operating margin -9.5%; net loss $43.5m.

Revenue includes $44.1m patent settlement; underlying revenue fell 2%. No debt.

Financial health: WeakRisk summary →
No reviews yet
View profile
AbbottHQ United States · North America
Diagnostics & IVDMedical devices & monitoring

FY2025 revenue $44.33bn (+5.7%); operating margin 18.2%; net income $6.52bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
AbridgeHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
AccurayHQ United States · North America
Medical devices & monitoring

FY2026 revenue $401.9m (-12.3%); operating margin -6.6%; net loss $49.2m.

Cash $41.2m; debt $147.9m.

Financial health: WeakRisk summary →
No reviews yet
View profile
AdvancedMDHQ United States · North America
Electronic health records (EHR/EPR)Revenue cycle, billing & claims

Recent change of ownership; current owner not yet confirmed from official filings.

Financial health not assessed until ownership and accounts are verified.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Altera Digital HealthHQ United States · North America
Electronic health records (EHR/EPR)Revenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Amazon Web ServicesHQ United States · North America
Infrastructure & cloud

Parent Amazon.com (AMZN) group FY2025 revenue $716.92bn (+12.4%); operating margin 11.2%; net income $77.67bn.

AWS segment: sales $128.7bn (+20%), operating income $45.6bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
Ambience HealthcareHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
AmwellHQ United States · North America
Telehealth & virtual care

FY2025 revenue $249.3m (-2.0%); operating margin -42.2%; net loss $95.7m.

No debt; $182.3m cash.

Financial health: WeakRisk summary →
No reviews yet
View profile
ArcadiaHQ United States · North America
Population health & analytics

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
ArmisHQ United States · North America
Cyber security

Recent change of ownership; current owner not yet confirmed from official filings.

Financial health not assessed until ownership and accounts are verified.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
athenahealthHQ United States · North America
Electronic health records (EHR/EPR)Patient engagement & accessRevenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
AvailityHQ United States · North America
Revenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BaxterHQ United States · North America
Medical devices & monitoring

FY2025 revenue $11.24bn (+5.7%); operating margin -2.7%; net loss $957.0m.

Continuing operations; operating loss after impairment and restructuring charges.

Financial health: WeakRisk summary →
No reviews yet
View profile
BD (Becton, Dickinson and Company)HQ United States · North America
Diagnostics & IVDMedical devices & monitoringPharmacy & medicines management

FY2026 revenue $19.46bn (+4.9%); operating margin 11.6%; net income $1.15bn.

Continuing operations; net income from continuing operations $1.42bn (+29%).

Financial health: StrongRisk summary →
No reviews yet
View profile
Beckman CoulterHQ United States · North America
Diagnostics & IVDLaboratory & pathology (LIMS)

Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
Big HealthHQ United States · North America
Digital therapeutics & appsMental health, community & social care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Bio-Rad LaboratoriesHQ United States · North America
Diagnostics & IVDLaboratory & pathology (LIMS)

FY2025 revenue $2.58bn (+0.7%); operating margin 1.8%; net income $759.9m.

Net income lifted by non-operating investment gains; operating profit was $47m.

Financial health: FairRisk summary →
No reviews yet
View profile
BiofourmisHQ United States · North America
Remote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Boston ScientificHQ United States · North America
Medical devices & monitoring

FY2025 revenue $20.07bn (+19.9%); operating margin 18.0%; net income $2.90bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
Cardinal HealthHQ United States · North America
ERP, finance & supply chainMedical devices & monitoring

FY2026 revenue $254.25bn (+14.0%); operating margin 1.0%; net income $1.71bn.

Cash $4.86bn; debt $8.89bn.

Financial health: FairRisk summary →
No reviews yet
View profile
CareCloudHQ United States · North America
Electronic health records (EHR/EPR)Revenue cycle, billing & claims

Listed (CCLD).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Carestream HealthHQ United States · North America
Imaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
CaresyntaxHQ United States · North America
Clinical AI & decision supportSurgical & theatre systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
CensinetHQ United States · North America
Cyber security

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile